Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Searle

Showing results (201-210 of 268) with videos related to

Pageof 27
Sort By:
International Immunology|May 1, 1993
MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathwaysS P Lee, L E Wallace, M Mackett, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1983
Clearance of injected radioactively labelled antibodies to tumour products by liposome-bound second antibodiesP A Keep, F Searle, R H Begent, et al.
European Journal of Cancer|August 1, 1978
Multivariate biochemical indicators of breast cancer: an evaluation of their potential in routine practiceD M Cowen, F Searle, A M Ward, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 10, 2025
Don't know much about geography? Decision support for the evaluation of patients with suspected high consequence infectious diseasesJacob E Lazarus, Michelle S Jerry, Lindsay Germaine, et al.
Placenta|March 22, 2006
Interleukin-17 expression in the human placentaS Pongcharoen, J Somran, S Sritippayawan, et al.
British Journal of Cancer|December 1, 1988
A cytotoxic agent can be generated selectively at cancer sitesK D Bagshawe, C J Springer, F Searle, et al.
Gene Therapy|April 21, 2001
Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53K S Lipinski, A H Djeha, E Krausz, et al.
International Journal of Cancer|April 15, 1984
Preparation and properties of mouse monoclonal antibody (W14A) to human chorionic gonadotropinF Searle, C S Partridge, A Kardana, et al.
Human Reproduction (Oxford, England)|June 21, 2011
Interaction between uterine natural killer cells and extravillous trophoblast cells: effect on cytokine and angiogenic growth factor productionGendie E Lash, Katsuhiko Naruse, Andrew Robson, et al.
Placenta|March 11, 2009
The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancyK Naruse, G E Lash, J N Bulmer, et al.
Pageof 27

Showing results (201-210 of 268) with videos related to

Sort By:
Pageof 27
International Immunology|May 1, 1993
MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathwaysS P Lee, L E Wallace, M Mackett, et al.
Oncodevelopmental Biology and Medicine : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1983
Clearance of injected radioactively labelled antibodies to tumour products by liposome-bound second antibodiesP A Keep, F Searle, R H Begent, et al.
European Journal of Cancer|August 1, 1978
Multivariate biochemical indicators of breast cancer: an evaluation of their potential in routine practiceD M Cowen, F Searle, A M Ward, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 10, 2025
Don't know much about geography? Decision support for the evaluation of patients with suspected high consequence infectious diseasesJacob E Lazarus, Michelle S Jerry, Lindsay Germaine, et al.
Placenta|March 22, 2006
Interleukin-17 expression in the human placentaS Pongcharoen, J Somran, S Sritippayawan, et al.
British Journal of Cancer|December 1, 1988
A cytotoxic agent can be generated selectively at cancer sitesK D Bagshawe, C J Springer, F Searle, et al.
Gene Therapy|April 21, 2001
Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53K S Lipinski, A H Djeha, E Krausz, et al.
International Journal of Cancer|April 15, 1984
Preparation and properties of mouse monoclonal antibody (W14A) to human chorionic gonadotropinF Searle, C S Partridge, A Kardana, et al.
Human Reproduction (Oxford, England)|June 21, 2011
Interaction between uterine natural killer cells and extravillous trophoblast cells: effect on cytokine and angiogenic growth factor productionGendie E Lash, Katsuhiko Naruse, Andrew Robson, et al.
Placenta|March 11, 2009
The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancyK Naruse, G E Lash, J N Bulmer, et al.
Pageof 27